Study highlights challenges of shared decision-making in advanced lung cancer care

The facility will deal with activities throughout the lifecycle of a vaccine, from product design to assessment of effectiveness. Credit: Mongkolchon Akesin / Shutterstock.com. The

First, HER2. Now, HER3. That’s the plan of at­tack for BioN­Tech in its ap­par­ent bid to fol­low in the foot­steps of an­ti­body-drug con­ju­gate leader Dai­ichi